Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

Safa, Houssein; H. Johnson, Daniel; Anh Trinh, Van; Rodgers, Theresa; Lin, Heather; E. Suarez‐Almazor, María; Fa’ak, Faisal; Saberian, Chantal; Yee, Cassian; A. Davies, Michael; Tummala, Sudhakar; Woodman, Karin; Abdel‐Wahab, Noha; Diab, Adi

doi:10.1186/s40425-019-0774-y

Public

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

Published in Journal for ImmunoTherapy of Cancer • Nov 21, 2019

Authors:

Houssein Safa

Daniel H. Johnson

Van Anh Trinh

Abstract

BACKGROUND: Myasthenia gravis (MG) is a rare but life-threatening adverse event of immune checkpoint inhibitors (ICI). Given the limited evidence, data from a large cohort of patients is needed to aid in recognition and management of this fatal complication. METHODS: We reviewed our institutional da...

Subject

Medicine

Myasthenia gravis

Adverse effect

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!